心电监护下泵入血管活性药物治疗重症心力衰竭的临床观察和心理干预

摘要

Objective To analyze the clinical observation and psychological intervention of the vasoactive drugs in the treatment of severe heart failure under ECG monitoring. Methods 100 patients with severe heart failure treated in our hospital from February 2015 to August 2016 were selected as the research object. They were randomly divided into the control group and the experimental group, with 50 patients in each group. The control group was treated with conventional treatment, including oxygen therapy and cardiac and diuretic therapy, the experimental group were given ECG monitoring and infusion of vasoactive drug therapy, using sodium nitroprusside drugs, and psychological intervention on the mental status of patients, strengthen communication and exchanges with patients, increasing confidence in treatment and the treatment compliance of patients. The clinical indexes of the experimental group and the control group were compared and analyzed. Results After the corresponding treatment, the number of invalid cases in the experimental group was 5 cases, the number of effective cases was 30 cases, and the number of effective cases was 15 cases. The number of invalid cases in the control group was 9 cases, the effective number was 27 cases, and the effective cases were 14 cases. The effective rate of treatment in the experimental group was 90%, which was significantly higher than that in the control group, and the effective rate was 82%, with statistical difference (P<0.05). There were no obvious adverse reactions in the experimental group and the control group. Conclusion The application of vasoactive drugs under ECG monitoring in the treatment of severe heart failure has better clinical efficacy and higher safety.%目的 分析心电监护下泵入血管活性药物治疗重症心力衰竭的临床观察和心理干预.方法 选取本院2015年2月~2016年8月收治的100例重症心力衰竭患者为研究对象,随机分为对照组和实验组,每组50例.对照组患者进行常规的治疗,包括吸氧治疗以及利尿和强心治疗,实验组患者给予心电监护下泵入血管活性药物治疗,选用硝普钠药物,并进行心理干预,关注患者的心理状态,加强与患者的沟通和交流,增加患者的治疗信心和治疗依从性.比较分析2组患者的相关临床指标.结果 治疗后,实验组治疗无效例数为5例,有效例数为30例,显效例数为15例.对照组治疗无效例数为9例,有效例数为27例,显效例数为14例.可得,实验组患者的治疗有效率为90.0%显著高于对照组有效率为82.0%,差异具有统计学意义(P<0.05).实验组与对照组患者均未出现明显的不良反应.结论 心电监护下泵入血管活性药物治疗重症心力衰竭临床疗效较好,安全性较高.